Cipla Ltd.

United States Food and Drug Administration (USFDA) has classified inspection conducted at Cipla’s wholly-owned subsidiary -- Sitec Labs’ analytical testing facility located in Mahape, Navi Mumbai as Voluntary Action Indicated (VAI). USFDA had conducted the inspection at said facility from February 18 to February 20, 2025. 

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.